Fear of progression is predicted by anxiety and self-efficacy but not disease-specific parameters in patients with Parkinson’s disease: data from a multicenter cross-sectional study
Objective: To examine Fear of progression (FoP) prevalence and to analyze FoP predictors in a large Parkinson’s disease (PD) sample. Background: FoP is a reactive…The results of DBS in patients with Parkinson’s disease for 10 years in Belarus
Objective: To study the efficiency and SE of DBS in PD patients in Republican Research and Clinical Center of Neurology and Neurosurgery in Belarus for…IgG to neurotensin in blood of Parkinson’s disease patients
Objective: The aim of the study was measurement of IgG to NT in blood plasma of Parkinson's disease patients. Background: Neurotensin (NT) is a 13-amino-acid…The profile of dysautonomia in the early stages of Parkinson’s disease and multiple system atrophy: the importance of using the SCOPA-AUT scale
Objective: To examine the profile of autonomic dysfunction and the utility of the SCOPA-AUT scale in distinguishing patients with early Parkinson's disease (PD) and MSA-parkinsonism (MSA-P)…Longitudinal Analysis of the Corticospinal Tract in Parkinson’s disease Patients
Objective: To assess longitudinal diffusion tensor imaging differences between PD patients in 8 corticospinal tract segments. Background: Parkinson’s disease (PD) is clinically defined by the presence…Preliminary real-world surgical data collection in RAD-PD
Objective: To describe surgical practices in a cohort of patients with Parkinson’s disease (PD) undergoing deep brain stimulation (DBS). Background: DBS is well-established to improve…A Novel Parkinson Shoe: A potential treatment of Unresponsive Freezing of Gait in Parkinson’s Disease Patients
Objective: To explore the effect of the novel PD shoe on FOG and gait parameters in PD patients with unresponsive FOG. Background: Freezing of gait (FOG) is…A prospective, controlled study of subthalamic stimulation in Parkinson’s disease: quality of life outcome at the 5-year follow-up
Objective: To compare the 60-months quality of life (QoL) effects of subthalamic stimulation (STN-DBS) to standard-of-care oral/transdermal medical therapy (MED) in Parkinson's disease (PD). Background:…Impact of dopamine replacement therapies on MDS-UPDRS II
Objective: To estimate the longitudinal effect of different dopamine therapies on the Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale Part II (MDS-UPDRS II) among…Predictors of the change in burden and strain among caregivers of Parkinson’s disease patients
Objective: The aim of the present study was to analyze the change in burden and strain after a 2-year follow-up in a cohort of caregivers…
- « Previous Page
- 1
- …
- 230
- 231
- 232
- 233
- 234
- …
- 338
- Next Page »